Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 10,000 shares at $160.75 ($1.6M) on 2018-08-14, disclosed to the SEC on 2018-08-15.
Open-market sale of $1.6M LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.13 | 1,600 | $255K | 15.9% |
| 2 | $159.93 | 7,100 | $1.1M | 71.0% |
| 3 | $160.75 | 1,300 | $209K | 13.1% |
| Total | $159.91 avg | 10,000 | $1.6M | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $2.7M | — | Filing → |
| LOXO | SELL | 2018-12-12 | $1.0M | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.2M | — | Filing → |